|Min SIP Amount||Not Supported|
|NAV||₹146.03 (16 Apr 2021)|
|Fund Started||10 Aug 2020|
|Fund Size||₹52 Cr|
|Divi's Laboratories Ltd.||Healthcare||Equity||4.5%|
|Dabur India Ltd.||FMCG||Equity||3.9%|
|Ambuja Cements Ltd.||Construction||Equity||3.9%|
|Havells India Ltd.||Engineering||Equity||3.8%|
|Tata Consultancy Services Ltd.||Technology||Equity||3.8%|
|Colgate-Palmolive (India) Ltd.||FMCG||Equity||3.8%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||3.8%|
ICICI Prudential Alpha Low Vol 30 ETF Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 10 Aug 2020. Kayzad Eghlim is the Current Fund Manager of ICICI Prudential Alpha Low Vol 30 ETF Growth fund.The fund currently has an Asset Under Management(AUM) of ₹52 Cr and the Latest NAV as of 16 Apr 2021 is ₹146.03.
The ICICI Prudential Alpha Low Vol 30 ETF Growth is rated Very High risk.
The scheme seeks to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.